Biobetter
Protein Manufacturing and Biologic Drug Purification Platform
Company Overview
Snapshot
Founded in September 2015 by Avi Tzur, Oded Shoseyov, and Dana Yarden, Biobetter operates with 11–50 employees. The company has raised $16.63M across 4 funding rounds from 7 investors.
Business overview
Biobetter develops a cost-effective, plant-based protein expression platform for producing complex growth factors essential for cellular agriculture. Its core technology utilizes tobacco plants as self-sustained bioreactors, combined with a novel purification method, to enable large-scale production of complex proteins at a significantly reduced cost, aiming for under $1 per gram. The company serves the cellular agriculture market and operates within the Agriculture & Food Technologies sector, focusing on sustainable proteins and biotechnology.
Strategic signal
In September 2022, Biobetter announced it had raised $10M in funding, a significant milestone that validates its approach to reducing the cost of growth factors for cultivated meat. This investment signals strong investor confidence in Biobetter's plant-based protein expression platform and its potential to address a critical bottleneck in the cultivated meat industry, positioning the company for accelerated development and market penetration.
Log in to access full profile ›Company Intelligence Q&A
- What is Biobetter's core technology?
- Biobetter's core technology involves using tobacco plants grown in open fields as self-sustained, renewable energy-driven bioreactors, combined with a novel purification method, to produce complex proteins at scale for cellular agriculture.
- When was Biobetter founded and by whom?
- Biobetter was founded in September 2015 by Avi Tzur, Oded Shoseyov, and Dana Yarden.
- What was a key strategic development for Biobetter in September 2023?
- In September 2023, Biobetter received a grant from the Israel Innovation Authority and EIT Food Accelerator Network, supporting its cultivated meat innovation efforts.
- What is Biobetter's primary goal regarding protein production costs?
- Biobetter aims to overcome the limitations of traditional protein production methods by reducing the cost of growth factor production to under $1 per gram.